Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the framingham heart study

Stroke

Volumn 45, Issue 5, 2014, Pages 1492-1494

  Romero, José Rafael ^a,d   Preis, Sarah R ^a,d   Beiser, Alexa ^a,d   Decarli, Charles ^b   Viswanathan, Anand ^c   Martinez Ramirez, Sergi ^c   Kase, Carlos S ^a,d   Wolf, Philip A ^a,d   Seshadri, Sudha ^a,d  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

Cerebral small vessel disease; Epidemiology; Risk factors

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR AMYLOIDOSIS;

CEREBRAL SMALL VESSEL DISEASE; EPIDEMIOLOGY; RISK FACTORS;

AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LIPOPROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84899899960     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.004130     Document Type: Article

References (13)

1. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165-174.
2. Gorelick PB. Cerebral microbleeds: evidence of heightened risk associated with aspirin use. Arch Neurol. 2009;66:691-693.
3. Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin- related intracerebral hemorrhage. Neurology. 2009;72:171-176.
4. Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43:2677-2681.
5. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11:241-249.
6. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70:1208-1214.
7. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke. 2004;35:1831-1835.
8. Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31:2982-2989.
9. Athyros VG, Tziomalos K, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Curr Opin Cardiol. 2010;25:406-410.
10. Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66:714-720.
11. Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, et al; International Stroke Genetics Consortium. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68:934-943.
12. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43:2149-2156.
13. Serebruany VL, Malinin AI, Hennekens CH. Statins increase risk of hemorrhagic stroke by inhibition of the PAR-1 receptor. Cerebrovasc Dis. 2007;24:477-479.